InvestSMART

Clever Culture Systems Limited (ASX: CC5) - Announcements

- Current share price for CC5 : $0.017

ASX company news and announcements for Clever Culture Systems Limited (CC5) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Clever Culture Systems Limited (CC5) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Clever Culture Systems Limited (CC5), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Clever Culture Systems Limited (CC5)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$37 Proposed issue of securities - CC5 3 Nov 2026 10:20AM $0.019 $0.017 fallen by 10.53%
$37 Funding Raised for Development of a New Benchtop Instrument 3 Nov 2026 10:20AM $0.019 $0.017 fallen by 10.53%
$37 Trading Halt 30 Oct 2026 9:08AM $0.019 $0.017 fallen by 10.53%
$37 Quarterly Activities/Appendix 4C Cash Flow Report 30 Oct 2026 8:30AM $0.019 $0.017 fallen by 10.53%
$37 Change of Registry Address Notification 29 Oct 2026 3:29PM $0.019 $0.017 fallen by 10.53%
$37 Advancing Sales Pipeline Underpins Growth Momentum 28 Oct 2026 8:21AM $0.019 $0.017 fallen by 8.11%
$37 PSC Biotech Partnership Expands US Pharma Sales Reach 14 Oct 2026 8:23AM $0.018 $0.017 fallen by 5.56%
$37 Proposed issue of securities - CC5 13 Oct 2026 5:27PM $0.018 $0.017 fallen by 5.56%
$37 Proposed issue of securities - CC5 13 Oct 2026 5:12PM $0.018 $0.017 fallen by 5.56%
$37 Notice of Annual General Meeting/Proxy Form 13 Oct 2026 4:54PM $0.018 $0.017 fallen by 5.56%
$37 Novo Nordisk Expand Use of APAS Independence 7 Sep 2026 9:56AM $0.014 $0.017 risen by 21.43%
$37 Appendix 4G 31 Aug 2026 10:26AM $0.015 $0.017 risen by 13.33%
$37 Corporate Governance Statement 31 Aug 2026 10:25AM $0.015 $0.017 risen by 13.33%
$37 Annual Report to shareholders 31 Aug 2026 10:25AM $0.015 $0.017 risen by 13.33%
$37 Appendix 4E 31 Aug 2026 9:44AM $0.016 $0.017 risen by 6.25%
$37 Application for quotation of securities - CC5 14 Aug 2026 9:37AM $0.014 $0.017 risen by 21.43%
$37 Change of Director's Interest Notice 13 Aug 2026 10:01AM $0.016 $0.017 risen by 6.25%
$37 Notification of cessation of securities - CC5 10 Aug 2026 10:02AM $0.015 $0.017 risen by 13.33%
$37 Proposed issue of securities - CC5 6 Aug 2026 10:03AM $0.017 $0.017 fallen by 0%
$37 Proposed issue of securities - CC5 6 Aug 2026 9:38AM $0.017 $0.017 fallen by 0%
$37 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jul 2026 9:39AM $0.017 $0.017 fallen by 0%
$37 Notification regarding unquoted securities - CC5 1 Jul 2026 4:42PM $0.023 $0.017 fallen by 26.09%
$37 Proposed issue of securities - CC5 29 Jun 2026 1:03PM $0.019 $0.017 fallen by 10.53%
$37 Notification regarding unquoted securities - CC5 23 Jun 2026 8:52AM $0.022 $0.017 fallen by 22.73%
$37 Updated Company Presentation 23 Jun 2026 8:30AM $0.022 $0.017 fallen by 22.73%

1 - 25 of 109 results

Page 1 of 5

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.